ViaLase announced the first patient was treated in a U.S. IDE clinical trial evaluating its femtosecond laser trabeculotomy ...

The MarketWatch News Department was not involved in the creation of this content.-- The first VisiPlate surgery in the US for the SAPPHIRE Trial was performed by Dr. Snyder of Sac ...

Please provide your email address to receive an email when new articles are posted on . Patients with migraine aged younger than 40 years had higher risk for open-angle glaucoma onset vs. those aged ...

Please provide your email address to receive an email when new articles are posted on . “Relaxation techniques have been reported to reduce IOP and improve neuroendocrine regulation of the ciliary ...

LONDON--(BUSINESS WIRE)--The global open-angle glaucoma therapeutics market is expected to post a CAGR of close to 4% during the period 2019-2023, according to the latest market research report by ...

A risk score incorporating genetic variants for open-angle glaucoma is accurate enough to help with diagnosis of the condition, an interim study reveals. Although hundreds of genetic changes are ...

DUBLIN--(BUSINESS WIRE)--The "Open-Angle Glaucoma (OAG) - Epidemiology Forecast - 2028" report has been added to ResearchAndMarkets.com's offering. The Open-angle glaucoma (OAG) epidemiology division ...

Taking the medication metformin hydrochloride was associated with reduced risk of developing the sight-threatening disease open-angle glaucoma in people with diabetes, according to a study published ...

Not all glaucoma cases are the same. There are actually several types of glaucoma, and your treatment will depend on what type of glaucoma you have. A small percentage of people with glaucoma have a ...

Avisi Technologies, Inc., an ophthalmic medical device company advancing novel, sight-saving technologies, announces the ...